G. Needham

发表

Quantitative assays of epidermal growth factor receptor in human breast cancer: Cut‐off points of clinical relevance

A. Harris, P. Chambers, J. Sainsbury, 1988, International journal of cancer.

Binding of urokinase to specific receptor sites on human breast cancer membranes.

G. Sherbet, A. Harris, G. Needham, 1987, British Journal of Cancer.

Natural history of the benign breast lump

V. Wadehra, J. Sainsbury, S. Nicholson, 1988, The British journal of surgery.

Low dose aminoglutethimide (125 mg twice daily) with hydrocortisone for the treatment of advanced postmenopausal breast cancer.

A. Harris, J. Farndon, B. Cantwell, 1986, Breast cancer research and treatment.

Relationship of membrane-bound tissue type and urokinase type plasminogen activators in human breast cancers to estrogen and epidermal growth factor receptors.

B. Angus, A. Harris, Farndon, 1988, Cancer research.

Relationships between oestrogen receptor, epidermal growth factor receptor, ER‐D5, and P24 oestrogen regulated protein in human breast cancer

A. Harris, B. Angus, C. Horne, 1988, The Journal of pathology.

EPIDERMAL-GROWTH-FACTOR RECEPTOR STATUS AS PREDICTOR OF EARLY RECURRENCE OF AND DEATH FROM BREAST CANCER

J. Farndon, C. Sainsbury, J. Richard, 1987, The Lancet.

Urokinase receptors in lung cancer and normal lung.

A. Harris, D. Veale, G. Needham, 1990, Anticancer Research.

Use of fine needle aspiration cytology with immediate reporting in the diagnosis of breast disease

V. Wadehra, J. Sainsbury, S. Nicholson, 1988, The British journal of surgery.

Endocrine effects of low dose aminoglutethimide with hydrocortisone--an optimal hormone suppressive regimen.

M. Dowsett, A. Harris, J. Farndon, 1986, Breast cancer research and treatment.

Binding ofurokinase tospecific receptor sites on humanbreast cancer membranes

G. Sherbet, A. Harris, G. Needham, 1987 .

New system for seafood safety.

G. Sherbet, A. Harris, G. Needham, 1998, Environmental health perspectives.